ArticleJPGN reports2022

Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis.

Giulia Jannone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.